Tyler Bussian

Stock Analyst at Brookline Capital

(0.12)
# 4,398
Out of 5,044 analysts
5
Total ratings
25%
Success rate
-29.08%
Average return
Main Sectors:

Stocks Rated by Tyler Bussian

Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $0.81
Upside: +1,018.01%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $6.74
Upside: +834.72%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.84
Upside: +1,090.62%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.10
Upside: +328.57%